XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.1
UNAUDITED CONSOLIDATED STATEMENTS OF NET INCOME - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenues:    
Net revenue $ 148,509 $ 131,704
Operating cost:    
Salaries and related costs 86,040 75,149
Rent, supplies, contract labor and other 30,100 28,662
Provision for credit losses 1,512 1,305
Total operating cost 117,652 105,116
Gross profit 30,857 26,588
Corporate office costs 13,859 11,556
Operating income 16,998 15,032
Other income and expense:    
Relief Funds 467 0
Change in fair value of contingent earn-out consideration (698) 0
Equity in earnings of unconsolidated affiliate 274 339
Interest and other income, net 64 46
Change in revaluation of put-right liability (149) 603
Interest expense - debt and other (2,560) (540)
Total other income and expense (2,602) 448
Income before taxes 14,396 15,480
Provision for income taxes 2,969 3,498
Net income 11,427 11,982
Less: net income attributable to non-controlling interest:    
Redeemable non-controlling interest - temporary equity (2,720) (2,557)
Non-controlling interest - permanent equity (1,297) (626)
Net income attributable to non-controlling interest (4,017) (3,183)
Net income attributable to USPH shareholders $ 7,410 $ 8,799
Basic earnings per share attributable to USPH shareholders (in dollars per share) $ 0.58 $ 0.67
Diluted earnings per share attributable to USPH shareholders (in dollars per share) $ 0.58 $ 0.67
Shares used in computation - basic (in shares) 13,025 12,937
Shares used in computation - diluted (in shares) 13,025 12,937
Dividends declared per common share (in dollars per share) $ 0.43 $ 0.41
Net Patient Revenue [Member]    
Revenues:    
Net revenue $ 126,581 $ 109,538
Other Revenue [Member]    
Revenues:    
Net revenue $ 21,928 $ 22,166